Nearly eight years ago, we formed the Typhoid Vaccine Acceleration Consortium (TyVAC). At that time, typhoid vaccine uptake in endemic countries was low and we didn’t have a prequalified typhoid ...
Read more
Author: Dr. Matthew Laurens, Center for Vaccine Development and Global Health, University of Maryland School of Medicine and TyVAC director
What does it cost to deliver TCV in Malawi?
Health economic analyses provide useful information when making decisions about introducing a new public health intervention like vaccines. The cost of a vaccination program, cost-effectiveness of vaccine introduction, and health ...
Read more
Evolving trends in drug resistance of typhoid fever in Bangladesh
Bangladesh is a typhoid-endemic country with a high burden of the disease. Yet, in the community, typhoid diagnosis is often made based on clinical symptoms rather than blood culture, the ...
Read more
La résistance aux médicaments rend urgente l’introduction des vaccins antityphoïdiques conjugués
Au cours du siècle dernier, nous avons été témoins de progrès remarquables en matière de santé mondiale. Les diagnostics et les traitements, ainsi que les vaccins et autres outils de ...
Read more
Drug resistance drives urgency for typhoid conjugate vaccines
Pour lire ce blog en français, veuillez cliquer ici. For the past century we have witnessed remarkable gains in global health progress. Diagnostics and treatments, plus, vaccines and other health ...
Read more
Time to take action with TCV in India
India has long grappled with a significant public health challenge—an alarmingly high typhoid burden. In 2017, more than half of the world’s typhoid cases were projected to have occurred in ...
Read more
How can Zimbabwe mitigate the risk of typhoid amid a drought?
Zimbabwe has faced recurring droughts in recent years, leading to severe water shortages. As a result, many Zimbabweans rely on alternative water sources, often resorting to shallow water that may ...
Read more
What have we learned from a 5-year-long study on typhoid conjugate vaccination in Bangladesh?
Typhoid conjugate vaccines (TCVs) are powerful tools to prevent typhoid. The World Health Organization (WHO) recommends administering a single dose of TCV in countries where typhoid is endemic and/or drug-resistant ...
Read more
Data for decision-making: Utilizing TyphiNET to understand drug-resistant typhoid and inform vaccine introduction
Typhoid, currently endemic in many parts of Asia and Africa, remains a major public health challenge. It can be effectively treated with antibiotics, but drug resistance is increasing. This makes ...
Read more
Community engagement bolsters typhoid conjugate vaccine introduction
National vaccine introduction campaigns require immense resources and support from government officials, health care workers, and community members. Local community knowledge of a vaccine before and during a campaign is ...
Read more
